|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-17
|
|
pubmed:abstractText |
To evaluate 6- and 9-month follow-up data including the effect on vision and anatomic outcome in patients treated with intravitreal bevacizumab for neovascular age-related macular degeneration (AMD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0950-222X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
82-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17891059-Age Factors,
pubmed-meshheading:17891059-Aged,
pubmed-meshheading:17891059-Angiogenesis Inhibitors,
pubmed-meshheading:17891059-Antibodies, Monoclonal,
pubmed-meshheading:17891059-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:17891059-Choroidal Neovascularization,
pubmed-meshheading:17891059-Female,
pubmed-meshheading:17891059-Follow-Up Studies,
pubmed-meshheading:17891059-Humans,
pubmed-meshheading:17891059-Injections,
pubmed-meshheading:17891059-Macular Degeneration,
pubmed-meshheading:17891059-Male,
pubmed-meshheading:17891059-Middle Aged,
pubmed-meshheading:17891059-Pigment Epithelium of Eye,
pubmed-meshheading:17891059-Retina,
pubmed-meshheading:17891059-Retinal Hemorrhage,
pubmed-meshheading:17891059-Retrospective Studies,
pubmed-meshheading:17891059-Statistics as Topic,
pubmed-meshheading:17891059-Tomography, Optical Coherence,
pubmed-meshheading:17891059-Treatment Outcome,
pubmed-meshheading:17891059-Visual Acuity
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.
|
|
pubmed:affiliation |
Department of Ophthalmology, Mater Misericordiae Hospital, Dublin, Ireland. ucclearly@mac.com
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Evaluation Studies
|
